- Home
- SIDU vs INKT Comparison
SIDU vs INKT Comparison
Compare SIDU & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- INKT
- Stock Information
- Founded
- SIDU 2012
- INKT 2017
- Country
- SIDU United States
- INKT United States
- Employees
- SIDU N/A
- INKT N/A
- Industry
- SIDU Telecommunications Equipment
- INKT Medicinal Chemicals and Botanical Products
- Sector
- SIDU Telecommunications
- INKT Health Care
- Exchange
- SIDU Nasdaq
- INKT Nasdaq
- Market Cap
- SIDU 30.0M
- INKT 28.9M
- IPO Year
- SIDU 2021
- INKT 2021
- Fundamental
- Price
- SIDU $1.87
- INKT $7.73
- Analyst Decision
- SIDU
- INKT Strong Buy
- Analyst Count
- SIDU 0
- INKT 2
- Target Price
- SIDU N/A
- INKT $37.50
- AVG Volume (30 Days)
- SIDU 589.8K
- INKT 14.8K
- Earning Date
- SIDU 08-18-2025
- INKT 08-12-2025
- Dividend Yield
- SIDU N/A
- INKT N/A
- EPS Growth
- SIDU N/A
- INKT N/A
- EPS
- SIDU N/A
- INKT N/A
- Revenue
- SIDU $3,860,985.00
- INKT N/A
- Revenue This Year
- SIDU $144.49
- INKT N/A
- Revenue Next Year
- SIDU N/A
- INKT N/A
- P/E Ratio
- SIDU N/A
- INKT N/A
- Revenue Growth
- SIDU N/A
- INKT N/A
- 52 Week Low
- SIDU $1.14
- INKT $4.56
- 52 Week High
- SIDU $7.65
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- SIDU 62.67
- INKT 57.39
- Support Level
- SIDU $1.64
- INKT $6.80
- Resistance Level
- SIDU $1.80
- INKT $7.88
- Average True Range (ATR)
- SIDU 0.13
- INKT 0.40
- MACD
- SIDU 0.02
- INKT 0.02
- Stochastic Oscillator
- SIDU 77.55
- INKT 58.86
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.